Discussions by the Ministry of Health, Labor and Welfare’s (MHLW) study group on the generic industry structure are reaching the last lap. Its final report - a draft of which will be presented later this month - is expected to…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY MHLW Issues Improvement Order to Janssen Pharmaceutical for GMP Violation
February 20, 2012
-
BUSINESS Diabetes Treatments: Their Development and Market
February 20, 2012
-
BUSINESS 6 SGLT-2 Inhibitors in Final Development Stage, Applications Expected in 2013
February 17, 2012
-
BUSINESS Sanofi-aventis Nichi-Iko Obtains Approval for Allegra Generic Ahead of Competitors
February 16, 2012
-
REGULATORY Over 30 Companies Target Nu-lotan Generic Listing in June, 60% Pricing Rule to Apply
February 15, 2012
-
BUSINESS Dispensing Pharmacies Set to Reopen in Disaster-Hit Areas
February 14, 2012
-
REGULATORY Healthcare Providers, Bill Payers in Face-Off Over Additional Premiums for Generic Name Prescriptions
February 13, 2012
-
BUSINESS Nichi-Iko to Shift Back Priority to Its Own Generics from Transferred Long-Listed Products
February 13, 2012
-
ORGANIZATION NPhA Compiles Draft Proposal for Mutual Understanding to Improve Distribution
February 10, 2012
-
BUSINESS Teijin Aims for ¥400 Billion in Sales in Healthcare by FY2020
February 9, 2012
-
BUSINESS Novartis President Mitani Says Diovan Patent Expiry an “Urgent Issue”
February 8, 2012
-
BUSINESS JCR to Push Joint Development with GSK, Including New Biopharmaceuticals
February 7, 2012
-
BUSINESS US, European Pharmaceutical Companies Supported by Steady Japan Business Growth
February 6, 2012
-
BUSINESS Number of MRs Breaks 60,000; Could Become Major Topic in Light of Strained Healthcare Finances
February 6, 2012
-
BUSINESS Eisai Says Impact from Generic Versions of Aricept Insignificant
February 3, 2012
-
BUSINESS Chugai Pharmaceutical to Promote Executive VP Kosaka as President and COO
February 2, 2012
-
BUSINESS Kyowa Kirin Development Chief Hanai Set to Become Company President
February 1, 2012
-
REGULATORY CSIMC General Assembly Establishes Premium for Prescriptions by Generic Name
January 31, 2012
-
REGULATORY JPO Decides Lipitor Crystal Form “Valid”, Sandoz Calls for Appeal
January 30, 2012
-
ORGANIZATION JPWA Board of Directors Approve By-Category Talks to Be Common Understanding
January 27, 2012
ページ
Whenever an excellent employee or leader leaves, it’s a blow to your organization.The departure of staff is an inevitable part of business, but in a fiercely competitive recruitment landscape like Japan, employee retention is a priority.Not only does retaining staff…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…